Rickettsiae are small (0.3 by 1.0 m), obligately intracellular bacteria that reside in arthropod hosts in at least part of their life cycle. Tick-transmitted Rocky Mountain spotted fever and louse-borne typhus fever are among the most virulent human infections known. All adequately studied Rickettsia species have a quantitatively major, immunodominant S-layer cell wall protein (OmpB), which is encoded as a 168-kDa precursor that undergoes posttranslational protease modification to the mature 135-kDa molecule (18). The spotted fever group rickettsiae differ from typhus group rickettsiae by possessing an additional major, immunodominant surface protein (OmpA) and have antigenic differences from typhus group rickettsiae in the lipopolysaccharides. OmpA contains a large, central, hydrophilic domain of 6 to 15 nearly identical tandem repeat units comprising 72 to 75 amino acids (aa) each.
Rickettsiae are small (0.3 by 1.0 m), obligately intracellular bacteria that reside in arthropod hosts in at least part of their life cycle. Tick-transmitted Rocky Mountain spotted fever and louse-borne typhus fever are among the most virulent human infections known. All adequately studied Rickettsia species have a quantitatively major, immunodominant S-layer cell wall protein (OmpB), which is encoded as a 168-kDa precursor that undergoes posttranslational protease modification to the mature 135-kDa molecule (18) . The spotted fever group rickettsiae differ from typhus group rickettsiae by possessing an additional major, immunodominant surface protein (OmpA) and have antigenic differences from typhus group rickettsiae in the lipopolysaccharides. OmpA contains a large, central, hydrophilic domain of 6 to 15 nearly identical tandem repeat units comprising 72 to 75 amino acids (aa) each.
We have developed mouse models that conform better to the target cells (endothelium) and pathology (disseminated vascular injury) of rickettsial diseases than previously available models, and they offer opportunities for major important advances in the study of rickettsial immunity (16, 45, 46) . Previous studies provided evidence that T lymphocytes are critical in the development of immune protection in rickettsial diseases (9, 23, 26, 28, 29, 43) . Recently performed research showed that adoptive transfer of immune CD4 or CD8 T lymphocytes protects mice against lethal disseminated endothelial infection with Rickettsia conorii (15) . Depletion of CD8, but not CD4, T lymphocytes converts infection with an ordinarily sublethal dose of R. conorii into an overwhelming fatal rickettsial infection in the majority of animals and a persistent symptomatic infection in the survivors. Thus, the evidence that T lymphocytes, particularly those of the CD8 subset, are crucial effectors of immunity applies broadly within the genus Rickettsia (45) . The potential importance of CD4 and CD8 T lymphocytes in human rickettsial infections is emphasized by the presence of large numbers of these cells in eschars of patients with R. conorii infection at the time of immune clearance of the rickettsiae (20) .
Vaccination with recombinant OmpA has protected guinea pigs against Rickettsia rickettsii and R. conorii, and purified native OmpB has protected vaccinated guinea pigs against Rickettsia typhi (2, 11, 38, 40) . Immunization of mice with recombinant Mycobacterium vaccae expressing rompA or rompA 2331-3976 and boosted with the homologous proteins (OmpA 755-1301 or OmpA 703-1288 , respectively) stimulated partial protection against lethal challenge with R. conorii (10) . The fragments OmpA 703-1288 , OmpA 1644-2213 , OmpB 451-846 , and OmpB 754-1308 stimulated T-lymphocyte proliferation and secretion of gamma interferon (IFN-␥) after primary immunization with DNA and booster immunization with the homologous recombinant proteins, and 100% of mice were protected against lethal challenge by immunization with the combination of the four fragments (12) . Based on these findings, it was hypothesized that OmpB contains protective elements and that some such elements are able to stimulate immune CD8 T lymphocytes. The specific aims of this study were to define the CD8 T-lymphocyte-stimulating epitopes of OmpB 451-846 of R. conorii at the oligopeptide level and identify the epitopes processed intracellularly and presented on the cell membrane by endothelial cells for the activation of CD8 T lymphocytes. The health impact of this research is that it will establish the knowledge and principles to enable the production of effective vaccines against rickettsial diseases.
incubated at room temperature for 20 min to allow DNA-Lipofectamine2000 complexes to form. Then, the DNA-Lipofectamine2000 complexes (100 l) were added directly to each well and mixed gently by rocking the plate back and forth. After 48 h, transfected cells were selected by growth in DMEM containing 10% BCS and 800 g of Geneticin (G418; GIBCO/BRL)/ml. NCTC cells transfected with the recombinant plasmids were used to evaluate the activation of CD8 T lymphocytes.
R. conorii-specific CD8 T-lymphocyte cell line. A CD8 T-lymphocyte cell line with high specificity for rickettsial antigens was developed by serial in vitro antigen stimulations. Five 6-to 8-week-old C3H/HeN male mice were inoculated intravenously with a sublethal dose of R. conorii (5 ϫ 10 2 PFU). All mice became ill and recovered by day 9 postinoculation. On that day, the murine spleens were harvested. Cell lines were derived from whole-spleen suspensions and from CD8 T lymphocytes purified from the same spleen suspensions. CD8 T lymphocytes were purified using selective columns (R & D Systems, Minneapolis, Minn.). In vitro stimulation was carried out in six-well plates containing a monolayer of paraformaldehyde-fixed, R. conorii-infected SVECs. Three milliliters of purified CD8 T lymphocytes at a concentration of 6 ϫ 10 5 cells/ml or 3 ml of spleen suspension at a concentration of 6 ϫ 10 6 cells/ml was added to each well. Three milliliters containing 6 ϫ 10 6 gamma-irradiated (2,300-rad) syngeneic naïve splenocytes/ml were added to each well as feeder cells. Plates were incubated at 37°C in a 5% CO 2 atmosphere. Lymphocytes were restimulated every week. Human recombinant interleukin-2 (Roche Molecular Biochemicals, Indianapolis, Ind.) was added to each well at a concentration of 10 U/ml from the second passage onwards.
Lymphocyte responses. T-lymphocyte responses were determined by measurement of IFN-␥ secretion and cell proliferation after antigen stimulation. IFN-␥ secretion was measured by use of a quantitative sandwich enzyme-linked immunosorbent assay kit (R & D Systems) according to the manufacturer's instructions. Results reported were the averages of triplicate samples. Standard deviations were determined by using the Microsoft Excel program. Differences among data sets were considered significant if P was Յ0.05; P values were determined by Student's t test with Microsoft Excel. The standard thymidine incorporation assay was used to quantify lymphocyte proliferation. The R. conorii-specific CD8 T-lymphocyte cell line was adjusted to a concentration of 10 6 cells/ml, and 100 l per well was aliquoted into 96-well plates. On day 5, 1 Ci of [ 3 H]thymidine was added per well, and the plates were incubated overnight at 37°C. Cells were harvested into GF/B (Packard Instruments Co., Meriden, Conn.) plates. After evaporation to dryness, 30 l of scintillation fluid was added to each well. [ 3 H]thymidine incorporation was determined in a beta counter (Top Count; Packard Instruments Co.). Lymphocyte proliferation was considered significant if the stimulation index (counts per minute of sample stimulated with antigen/ counts per minute of sample without antigen) was greater than 3. These experiments were repeated three times.
Cytotoxic T-lymphocyte (CTL) assays. CTL assays were performed according to the standard method reported previously (3). Since the major target cells of rickettsial infection in humans and in the C3H/HeN mouse model are the endothelial cells, the R. conorii-infected MHC class I-matched endothelial cell line, SVEC4-10 (H-2 k ), was chosen as the target cells in the CTL assay (46) . The effector cells were a CD8 T-lymphocyte cell line reactive against R. conorii. The percentage of target cell lysis was calculated by the following formula: [(counts per minute of the experiment Ϫ counts per minute spontaneously released)/ (counts per minute of the maximum release Ϫ counts per minute spontaneously released)] ϫ 100.
CD8 T-cell epitope mapping of OmpB 451-846 by using synthetic peptides. The amino acid sequences of polypeptides that stimulate CD8 T-cell activation were further mapped by using overlapping synthetic peptides. Each peptide contained nine amino acid residues, and two adjacent peptides overlapped by four or five residues. The peptides were custom synthesized (Bio-Synthesis Inc., Lewisville, Tex.). We have established a murine CD8 T-cell line reactive against the antigens of R. conorii. These cells were used for T-cell epitope mapping of OmpB. The mouse CD8 T lymphocytes were adjusted to 10 6 cells/ml, and 0.1 ml was aliquoted into each well of 96-well plates. The synthetic peptides were diluted and added to duplicate wells at a 20 M concentration. Each well also contained 10 5 antigen-presenting cells (SVECs) and interleukin-2 (one unit per well). The ability of these peptides to activate CD8 T lymphocytes in vitro was tested by lymphocyte proliferation, IFN-␥ production, and CTL assay. (Fig. 1) . Their sizes were as expected. These PCR products were cloned into pcDNA3.1/ CT-GFP-TOPO vector. Clones containing these fragments in the right orientation were selected and used to transfect NCTC fibroblast cells.
RESULTS

Cloning and expression of rickettsial
Transfection and selection of antigen-expressing fibroblast cells. Plasmids containing rickettsial OmpB 451-846 gene fragments were purified and successfully transfected with Lipofectamine2000 into NCTC fibroblast cells, which were derived from C3H/HeN mice with the same MHC class I haplotype (H-2 k ). The plasmid vector pcDNA3.1/CT-GFP-TOPO contains a neomycin resistance cassette that allows the selection of transfected mammalian cells with a closely related antibiotic, Geneticin (G418). Mammalian cells are more sensitive to Geneticin than to neomycin. The sensitivity varies among cell lines, and the killing dose for NCTC cells was determined as 800 g/ml. These Taq polymerase-amplified PCR products were expressed as C-terminal fusion products with the green fluorescent protein (GFP). Expression of rickettsial fragments was determined by detection of fluorescent cells with a filter set with a maximum excitation of 450 nm and a maximum emission of 508 nm (Omega Optical Inc., Brattleboro, Vt.).
Establishment of a CD8 T-lymphocyte cell line reactive against R. conorii. The R. conorii-specific CD8 T-lymphocyte populations derived from whole-spleen suspensions reached 95% purity (the other 5% may be CD4 lymphocytes from the irradiated feeder cells) after four passages in vitro (Fig. 2) . This cell line is a very useful tool for the identification of the rickettsial CD8 T-lymphocyte epitopes. stimulated the secretion of IFN-␥ by immune CD8 T lymphocytes at significantly higher (P Յ 0.05) levels than those of the controls ( Fig. 1 and 3) . Transfected NCTC cells expressing OmpB 458-652 , nontransfected NCTC cells, or GFP-transfected NCTC cells did not stimulate lymphocyte proliferation or IFN-␥ secretion. The epitopes of OmpB 595-744 were further mapped by subcloning the fragment into three smaller fragments. Proliferation of immune CD8 T lymphocytes was observed after stimulation by NCTC cells transfected with OmpB 689-744 (stimulation index, 3.297 Ϯ 0.040). NCTC cells transfected with OmpB 689-744 stimulated the secretion of IFN-␥ by immune CD8 T lymphocytes at significantly higher (P Յ 0.05) levels than those of the controls ( Fig. 1 and 4) . Transfected NCTC cells expressing subclone OmpB 595-654 or OmpB 645-692 , nontransfected NCTC cells, and GFP-transfected NCTC cells did not stimulate lymphocyte proliferation or IFN-␥ secretion.
Presentation of fragments representing ompB
CD8 T-cell epitope mapping of OmpB with synthetic peptides. NCTC cells transfected with a mammalian expression vector expressing the fragments OmpB 689-744 and OmpB 739-848 stimulated immune CD8 T lymphocytes, suggesting the presence of CD8 T-lymphocyte-stimulating epitopes. CD8 Tlymphocyte epitopes were mapped on OmpB 689-744 and OmpB 739-848 by using overlapping synthetic peptides. The ability of each of these synthetic peptides to activate CD8 T lymphocytes was tested in vitro by IFN-␥ secretion, lymphocyte proliferation, and CTL assay. Five synthetic peptides, SKG VNVDTV (OmpB 708-716 ), ANVGSFVFN (OmpB 735-743 ), IVS GTVGGQ (OmpB 749-757 ), ANSTLQIGG (OmpB 789-797 ), and IVEFVNTGP (OmpB 812-820 ), incubated with SVECs induced secretion of IFN-␥ at significantly higher levels (P Յ 0.05) than did the controls (Fig. 5) . Three of these five peptides, SKG VNVDTV (OmpB 708-716 ), ANSTLQIGG (OmpB 789-797 ), and IVEFVNTGP (OmpB 812-820 ), also stimulated the proliferation of immune CD8 T lymphocytes (Fig. 6 ). Significantly higher levels of specific CTL killing were observed with the same three synthetic peptides, SKGVNVDTV (OmpB 708-716 ), ANS TLQIGG (OmpB 789-797 ), and IVEFVNTGP (OmpB 812-820 ) (Fig. 7) .
DISCUSSION
Boutonneuse fever caused by R. conorii has a high prevalence in southern Europe, parts of western Asia, and Africa. Fatalities occur particularly in patients who are elderly or who have other host-dependent risk factors (33, 42) . Infection with spotted fever group rickettsial organisms elicits protective im- 
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munity that is solid and long-lasting (34) . The immune mechanisms depend largely on T lymphocytes (9, 15, 21, 23, 26, 28, 29, 43) . This report represents for the first time the identification of three CD8 T-lymphocyte epitopes in OmpB of R. conorii. These epitopes illustrate an approach to selecting candidate antigens for rickettsial subunit vaccine development. Currently, there is no rickettsial vaccine available that is close to being effective and acceptable. Three vaccines have been developed for prevention of Rocky Mountain spotted fever: a killed rickettsial preparation of infected ticks developed in 1924, a killed rickettsial vaccine from infected yolk sacs of embryonated hen's eggs developed in 1938, and a killed rickettsial vaccine developed from cell culture in the 1970s (7, 8, 22, 37) . However, all these vaccines failed to confer effective immune protection (6, 13) . The use of molecular approaches to development of rickettsial vaccines is quite clearly making significant progress. Rickettsial vaccine development has been thwarted by the difficulty of manipulating these organisms outside viable host cells. Knowledge of the protective immune effector mechanisms and how to stimulate them is a rational prerequisite to an ultimately successful vaccine regimen (41) . Development of rickettsial vaccines will have a significant effect on the prevention of these life-threatening, diagnostically difficult diseases.
The main goal of this study was to identify CD8 T-lymphocyte epitopes of R. conorii. Because CD8 T cells play important roles in resistance to infection with rickettsiae, effective vaccines against rickettsiosis will likely require identification of antigens that contain CD8 T-cell epitopes. CD8 T-cell epitopes consist of 8-or 9-aa peptides that are selected for presentation based on MHC class I allele-specific binding motifs and their ability to survive proteolytic digestion in the host cell. The subunit strategy for development of an effective rickettsial vaccine relies on identification of antigens and the precise epitope recognized by the protective CD8 T cells. In this study, the plasmid vector pcDNA3.1/CT-GFP-TOPO (Invitrogen) was used for the expression of the OmpB fragments in NCTC fibroblast cells. This vector system is associated with fewer toxic effects of intact bacterial proteins in the host cells, since the approach is designed for expression of gene fragments.
So far, identification of CD8 T-lymphocyte epitopes has been focused mainly on facultatively intracellular bacteria. and lungs of infected mice. During this study, we combined genetic and biochemical means in an attempt to identify CD8 T-lymphocyte epitopes from OmpB of R. conorii. Our results showed that three synthetic peptides of OmpB 451-846 , SKG VNVDTV (OmpB 708-716 ), ANSTLQIGG (OmpB 789-797 ), and IVEFVNTGP (OmpB 812-820 ), induced secretion of IFN-␥ and stimulated the proliferation of immune CD8 T lymphocytes and specific CTL killing at significantly higher levels than the controls did. In our study, at effector/target ratios of 3, 10, and 30, increasing levels of epitope-specific CTL lysis were observed (Fig. 7) . Protective immunity against rickettsiae is achieved by a complex interaction of responses mediated by CD4 and CD8 T lymphocytes, macrophages, NK cells, antibodies, cytokines, and chemokines (1, 39) . CTL activity, which is expressed by immune CD8 T lymphocytes, appears to be crucial to recovery from rickettsial infection (44) . Depletion of CD8 T lymphocytes results in the establishment of persistent R. conorii infection in mice associated with increased mortality after an ordinarily sublethal dose of rickettsiae (15) . IFN-␥ secretion by and CTL activity of immune CD8 T lymphocytes are involved, but the specifics are yet to be determined (14) .
This research extends the knowledge of the role of OmpB as an immunogen and the relevance of the response of CD8 T lymphocytes to such antigens. Epitopes with strong CD8 stimulatory capability will represent good candidates for rickettsial vaccine development because they stimulate a relevant arm of the immune response against these intracellular bacteria. The identification of potential CD8 T-lymphocyte epitopes at the oligopeptide level was addressed for the H-2 k haplotype. Future progress in subunit vaccine development will require identification of CD8 T-lymphocyte epitopes that stimulate human CD8 T lymphocytes via MHC class I presentation.
